Statement on Supreme Court Decision Upholding Health Care Law
WASHINGTON, June 25 – Sen. Bernie Sanders (I-Vt.) issued the following statement on Thursday after the Supreme Court ruled 6-3 in the case of King v. Burwell to uphold the Affordable Care Act: “The Supreme Court recognized the common-sense reading of the Affordable Care Act that Congress intended to help all eligible Americans obtain health insurance whether they get it
Sanders Backs Voting Rights Bill
WASHINGTON, June 24 – Sen. Bernie Sanders (I-Vt.) issued the following statement on Wednesday endorsing legislation introduced in the Senate to restore the Voting Rights Act: “The Supreme Court’s 2013 decision gutting the Voting Rights Act was a shameful step backward. The critical civil rights law which protected voters in places with a history of discrimination is as necessary today
Senate Committee Passes Transportation Bill
WASHINGTON, June 24 – A Senate panel today advanced a six-year, $278 billion transportation funding bill that includes more than $1.3 billion for Vermont to maintain its road and bridges. “It is no secret that our infrastructure is crumbling,” said Sen. Bernie Sanders (I-Vt.), who helped draft the bill as a member of the transportation subcommittee. “One of every nine
Corporate America Wins Again
WASHINGTON, June 23 – Sen. Bernie Sanders expressed deep disappointment on Tuesday after the Senate voted 60-37 to cut off debate and advance legislation that would grant President Barack Obama powers to complete a major Pacific trade accord. “The vote today – pushed by multi-national corporations, pharmaceutical companies and Wall Street – will mean a continuation of disastrous trade policies
Sanders Statement on House Trade Vote
WASHINTON, June 18 – Sen. Bernie Sanders (I-Vt.) issued the following statement today after the House, in an about face, revived a bill to give President Barack Obama authority to send Congress trade agreements it can reject or ratify but not change: “I am extremely disappointed but not surprised that the House put the interests of powerful multi-national corporations, drug